Lobbying Information
Subject Matters
- Aboriginal Affairs
- Economic Development
- Health
- Industry
- Intellectual Property
- International Trade
- Research and Development
- Science and Technology
Subject Matter Details
Legislative Proposal, Bill or Resolution
- o Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.
Policies or Program
- Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines
- Federal Government First Nations and Inuit Health Branch program with respect to health services.
- Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
- Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector
- Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Correctional Service of Canada (CSC)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
6711 Mississauga Road, suite 600
Mississauga, ON L5N 2W3
Canada
Telephone number:
905-363-8001
Client representative
Bobby Sutherland, Senior Director, Government Affairs
Parent Company Information
- Gilead Sciences Inc
-
333 Lakeside Drive
Foster City, CA 94404
United States of America
Coalition Members Information
Gilead Sciences Canada Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Gilead Sciences Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
Gilead Sciences Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
Greg Maceachern
|
Public offices held
Business address:
1 Rideau Street
Suite 700
OTTAWA, ON K1S 5K9
Canada
Telephone number:
613-790-0833
Consultant Firm and Address
Firm:
Proof Strategies / Proof Stratégies
Address:
1 Rideau Street , Suite 700
Ottawa, ON K1N 8S7
Canada
Telephone number:
613-790-0833
